Medication update.
Slagle
Mark
M
BCPS, Johnson City, Tenn, USA.
D016642:Bupropion / Q000494:pharmacology / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000494:pharmacology / Q000627:therapeutic use; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009538:Nicotine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D011109:Polymethacrylic Acids / Q000494:pharmacology / Q000627:therapeutic use; D011145:Polyvinyls / Q000494:pharmacology / Q000627:therapeutic use; D016540:Smoking Cessation; D061485:Tobacco Use Cessation Devices
D000697:Central Nervous System Stimulants; D018765:Dopamine Uptake Inhibitors; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D016642:Bupropion; D009538:Nicotine